Literature DB >> 3141474

New selective medium for Pseudomonas aeruginosa with phenanthroline and 9-chloro-9-[4-(diethylamino)phenyl]-9,10-dihydro-10- phenylacridine hydrochloride (C-390).

M E Campbell1, S W Farmer, D P Speert.   

Abstract

A new selective medium (PC agar) for the isolation of Pseudomonas aeruginosa was developed, consisting of 30 micrograms of 9-chloro-9-[4-(diethylamino)phenyl]-9,10-dihydro-10-phenylacridine hydrochloride (C-390) per ml and 30 micrograms of phenanthroline per ml in Columbia agar. PC agar was superior to phenanthroline, C-390, acetamide, and cetrimide agars for the selective growth of P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141474      PMCID: PMC266749          DOI: 10.1128/jcm.26.9.1910-1912.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  THE IDENTIFICATION OF ATYPICAL STRAINS OF PSEUDOMONAS AERUGINOSA.

Authors:  A H WAHBA; J H DARRELL
Journal:  J Gen Microbiol       Date:  1965-03

Review 2.  Selective antimicrobial modulation of the intestinal flora. Prophylaxis against infection in neutropenic patients.

Authors:  H F Guiot; R van Furth
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

3.  Selective media for the quantitation of bacteria in cystic fibrosis sputum.

Authors:  K Wong; M C Roberts; L Owens; M Fife; A L Smith
Journal:  J Med Microbiol       Date:  1984-04       Impact factor: 2.472

4.  Use of 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan as a primary medium for recovery of Pseudomonas aeruginosa from clinical specimens.

Authors:  G F Araj
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

5.  Evaluation of Pseudosel agar as an aid in the identification of Pseudomonas aeruginosa.

Authors:  D W Lambe; P Stewart
Journal:  Appl Microbiol       Date:  1972-02

6.  Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria.

Authors:  H F Guiot; J W van der Meer; R van Furth
Journal:  J Infect Dis       Date:  1981-05       Impact factor: 5.226

7.  New selective agent for isolation of Pseudomonas aeruginosa.

Authors:  L M Marold; R Freedman; R E Chamberlain; J J Miyashiro
Journal:  Appl Environ Microbiol       Date:  1981-04       Impact factor: 4.792

8.  Prediction by surveillance cultures of bacteremia among neutropenic patients treated in a protective environment.

Authors:  M L Cohen; M T Murphy; G W Counts; C D Buckner; R A Clift; J D Meyers
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

9.  Acetamide broth for isolation of Pseudomonas aeruginosa from patients with cystic fibrosis.

Authors:  N M Kelly; F R Falkiner; C T Keane
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

10.  4-h Identification of Pseudomonas aeruginosa with 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan.

Authors:  J R Davis; C E Stager; G F Araj
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

View more
  11 in total

1.  Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.

Authors:  D P Speert; S W Farmer; M E Campbell; J M Musser; R K Selander; S Kuo
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

2.  Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.

Authors:  D P Speert; M E Campbell; S W Farmer; K Volpel; A M Joffe; W Paranchych
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

3.  Multiparametric analysis of waterline contamination in dental units.

Authors:  J Barbeau; R Tanguay; E Faucher; C Avezard; L Trudel; L Côté; A P Prévost
Journal:  Appl Environ Microbiol       Date:  1996-11       Impact factor: 4.792

4.  Four epitopes of Pseudomonas aeruginosa elastase defined by monoclonal antibodies.

Authors:  J Lagacé; M Fréchette
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

5.  Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis.

Authors:  E Mahenthiralingam; M E Campbell; D P Speert
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo.

Authors:  Holly K Huse; Taejoon Kwon; James E A Zlosnik; David P Speert; Edward M Marcotte; Marvin Whiteley
Journal:  MBio       Date:  2010-09-21       Impact factor: 7.867

7.  Quorum-sensing control of antibiotic resistance stabilizes cooperation in Chromobacterium violaceum.

Authors:  Kara C Evans; Saida Benomar; Lennel A Camuy-Vélez; Ellen B Nasseri; Xiaofei Wang; Benjamin Neuenswander; Josephine R Chandler
Journal:  ISME J       Date:  2018-01-26       Impact factor: 10.302

8.  Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection.

Authors:  C Beaulac; S Clément-Major; J Hawari; J Lagacé
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

9.  Identification of Pseudomonas aeruginosa by using a disk of phenanthroline and 9-chloro-9-[4-(diethylamino)phenyl]-9,10-dihydro-10-phenylacridine hydrochloride and by cell agglutination testing with monoclonal antibodies.

Authors:  S Fujita; A Tonohata; T Matsuoka; N Okado; T Hashimoto
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

10.  Pseudomonas aeruginosa infections in patients, hospital means, and personnel's specimens.

Authors:  Hossein Fazeli; Reza Akbari; Sharareh Moghim; Tahmineh Narimani; Mohammad Reza Arabestani; Ali Reza Ghoddousi
Journal:  J Res Med Sci       Date:  2012-04       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.